Skip to main content
Ingredients

(3r,6s)-3-[(5r,9r,10r,13s,14s,16s,17s)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-prop-1-en-2-yloxan-2-one

C30H44O4

Entity Type
Ingredients
Relation Groups
2
Relation Preview
4

Basic Information

Grouped by core information, identifiers, and descriptions.

Core Information

Name
(3r,6s)-3-[(5r,9r,10r,13s,14s,16s,17s)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-prop-1-en-2-yloxan-2-one
Molecular Formula
C30H44O4
Molecular Weight
No data
Canonical SMILES
CC(=C)C1CCC(C(=O)O1)C2C(CC3(C2(CCC4C3=CCC5C4(CCC(=O)C5(C)C)C)C)C)O
Isomeric SMILES
CC(=C)[C@@H]1CC[C@@H](C(=O)O1)[C@@H]2[C@H](C[C@]3([C@]2(CC[C@H]4C3=CC[C@@H]5[C@@]4(CCC(=O)C5(C)C)C)C)C)O
InChI
InChI=1S/C30H44O4/c1-17(2)22-10-8-18(26(33)34-22)25-21(31)16-30(7)20-9-11-23-27(3,4)24(32)13-14-28(23,5)19(20)12-15-29(25,30)6/h9,18-19,21-23,25,31H,1,8,10-16H2,2-7H3/t18-,19+,21+,22+,23+,25-,28-,29+,30-/m1/s1
Oral Bioavailability
27.696
Drug Likeness
0.397
DL Score
No data
Caco-2 Permeability
No data
ALogP
No data
Bioavailability Score
No data

Identifiers

InChI Key
No data
PubChem CID
No data

Description and Extensions

Toxicity Information
No data
Related

Direct relations and traceable candidates grouped by relation type.

Active Targets

ingredient target3 Targets
02
NR3C1
nuclear receptor subfamily 3 group C member 1
nuclear receptor subfamily 3 group C member 1
03
NR3C2
nuclear receptor subfamily 3 group C member 2
nuclear receptor subfamily 3 group C member 2